Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Jul 08, 2026
Albemarle (ALB) Stock Slides -17% Over 30 Days Amid Lithium Oversupply Concerns

Albemarle (ALB) Stock Slides -17% Over 30 Days Amid Lithium Oversupply Concerns

Key Takeaways

  • Albemarle (ALB) shares have fallen approximately 17% over the last 30 days, dropping from around $155 to near $129, driven by renewed lithium market oversupply fears.
  • A sharp sell-off in late June and early July accelerated losses, with the stock logging a seven-day losing streak that erased roughly 22% of its value in a single week.
  • Falling lithium carbonate prices in China, combined with expectations of new supply from CATL's Jianxiawo mine restart, rattled investor sentiment across the lithium sector.
  • Analyst downgrades and price-target cuts from Mizuho and Rothschild Redburn added pressure, while insider selling by the CEO and other executives weighed on confidence.
  • Over the broader quarter, ALB has declined more than 27%, reversing gains from earlier in 2026 despite strong first-quarter earnings that beat Wall Street estimates.

A Closer Look at Albemarle and Its Market Position

Albemarle Corporation is one of the world's largest lithium producers and a leading global specialty chemicals company. Headquartered in Charlotte, North Carolina, the company operates across two primary business segments: Energy Storage, which develops and manufactures lithium compounds including lithium carbonate and lithium hydroxide for electric vehicle batteries and grid storage; and Specialties, which produces bromine-based solutions for fire safety, oil and gas drilling, water treatment, and pharmaceuticals. Albemarle's integrated operations span lithium mining and refining assets in Chile, Australia, and the United States, positioning it as a critical supplier in the global energy transition. Investors closely follow ALB stock as a bellwether for lithium demand, EV adoption trends, and broader clean-energy policy developments.

ALB Stock Performance: Recent 30 Days and the Broader Quarter

Over the last 30 days, Albemarle shares have declined approximately 17%, falling from a closing price of $155.44 on June 5, 2026, to $129.02 on July 7, 2026. The sell-off intensified in late June, when the stock entered a seven-day losing streak that alone accounted for a cumulative drop of roughly 22%. The decline pushed ALB well below its 50-day moving average of approximately $171 and its 200-day moving average near $149, signaling broad-based technical weakness. To put this in context, I ran a quick check with Tickeron’s AI Screener to see how the stock compares to others in the industry.

The quarterly picture is even starker. From levels above $215 in mid-April, ALB has shed more than 27% over the trailing three-month period. This reversal erased most of the stock's year-to-date gains and stands in sharp contrast to the broader S&P 500, which posted positive returns over the same timeframe. The divergence highlights how tightly Albemarle's valuation remains tied to lithium commodity prices rather than broader equity market momentum.

Key Drivers Behind the Recent 30-Day Decline

The primary catalyst behind the 30-day decline was a sharp deterioration in lithium market sentiment. Lithium carbonate prices in China fell to a ten-week low in late June, as traders braced for the potential restart of CATL's massive Jianxiawo mine. The prospect of additional supply entering an already fragile market reignited fears of a global lithium glut, sending shockwaves through lithium-linked equities. Albemarle, as the sector's largest pure-play producer, bore the brunt of the selling pressure.

Compounding the commodity headwinds, several analyst actions weighed on the stock. On July 1, Mizuho maintained a Neutral rating but lowered its price target from $205 to $185. Rothschild Redburn followed with a more bearish outlook, cutting its target to $170 and warning that a return to market surplus in 2027 would erode the investment case for major producers. The firm specifically flagged a three-month lag between spot lithium price improvements and Albemarle's realized pricing, suggesting near-term earnings may not reflect any commodity recovery.

Insider activity also drew investor attention. CEO J Kent Masters sold over 16,000 shares in May at an average price near $184, and no insider purchases were recorded over the past six months. Additionally, the announced retirement of Chief Accounting Officer Donald J. LaBauve Jr. and broader institutional repositioning—including significant stake reductions by Castle Hook Partners and Manning & Napier—added to the cautious tone surrounding the stock.

Factors Behind the Quarterly Performance

Albemarle's quarterly decline reflects a broader narrative of lithium market volatility and shifting analyst expectations. The stock surged above $215 in mid-April, fueled by optimism around recovering lithium prices and strong first-quarter 2026 results reported on May 6. In that report, Albemarle posted net sales of $1.43 billion, up 33% year-over-year, and adjusted EBITDA of $664 million, a 148% increase. Earnings per share of $2.95 handily beat consensus estimates of $1.24.

However, the post-earnings rally proved short-lived. By late May, concerns about the sustainability of lithium price gains began to surface. Rothschild Redburn downgraded the stock in April, warning that pricing benefits would peak in the third quarter before fading. Baird also moved to the sidelines, citing supply concerns. The phased removal of Chinese export tax rebates for batteries, scheduled to begin in 2027, prompted elevated production in 2026 that pulled forward demand—setting the stage for a potential demand deceleration next year. As supply ramped up across China, Argentina, and the U.S., analysts projected lithium carbonate equivalent prices could fall to $15-$16 per kilogram by year-end, undermining the bullish case that had driven ALB's earlier gains.

Using AI Tools to Navigate Volatile Stocks Like ALB

Navigating volatile stocks like Albemarle requires timely data and disciplined strategy. In my own process, I often turn to Tickeron’s Trending AI Robots for additional perspective. This page offers access to a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers in real time. Rather than displaying every available bot, it highlights only the top-performing and most relevant AI robots based on recent performance metrics, strategy effectiveness, and market conditions. Each bot operates with a distinct approach—ranging from short-term momentum strategies to longer-term trend-following models—allowing users to find tools aligned with their individual trading style. For those seeking to complement their own analysis with data-driven automation, exploring the Trending AI Robots page can provide a practical starting point.

Looking Ahead: What to Watch for ALB Stock

Looking ahead, several factors will be critical for Albemarle's stock trajectory. The company's next quarterly earnings report will be closely scrutinized for updates on realized lithium pricing, volume growth, and progress on cost-reduction initiatives. Management's commentary on the supply-demand balance—particularly regarding Chinese production trends and CATL's mine restart timeline—will be essential for gauging the near-term pricing environment.

Macroeconomic developments, including electric vehicle sales data from China, Europe, and North America, will continue to influence lithium demand expectations. Battery energy storage system (BESS) deployment, which has grown at roughly 40% annually, represents an increasingly important demand driver that could help offset any softness in EV adoption. On the supply side, investors should monitor production ramp-ups in Argentina and the U.S., as well as any policy shifts related to critical mineral subsidies or trade restrictions. While analyst price targets remain widely dispersed—ranging from $170 to $264—the median target near $215 suggests potential upside if lithium markets stabilize, though near-term volatility is likely to persist.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ALB

ALB's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ALB turned positive on July 22, 2026. Looking at past instances where ALB's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on ALB as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ALB moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALB crossed bullishly above the 50-day moving average on August 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALB advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for ALB moved below the 200-day moving average on July 24, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALB broke above its upper Bollinger Band on August 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALB entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.103) is normal, around the industry mean (7.001). ALB's P/E Ratio (530.556) is considerably higher than the industry average of (39.393). Projected Growth (PEG Ratio) (0.959) is also within normal values, averaging (2.393). Dividend Yield (0.011) settles around the average of (0.019) among similar stocks. P/S Ratio (3.078) is also within normal values, averaging (70.976).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 12.06B. The market cap for tickers in the group ranges from 47 to 224.76B. LIN holds the highest valuation in this group at 224.76B. The lowest valued company is GTBT at 47.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 6%. CITR experienced the highest price growth at 21%, while LWLG experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was 25%. For the same stocks of the Industry, the average monthly volume growth was -14% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 58
Price Growth Rating: 51
SMR Rating: 77
Profit Risk Rating: 81
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
ALB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of specialty polymers, chemicals and related products

Industry ChemicalsSpecialty

Profile
Details
Industry
Chemicals Specialty
Address
4250 Congress Street
Phone
+1 980 299-5700
Employees
9000
Web
https://www.albemarle.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.